Mar 25, 2019

Philips Carla Kriwet talks innovation at FORTUNE Brainstorm Health

Estimated reading time: 1-3 minutes

Head of Connected Care at Philips joins health leaders to discuss a global approach to curing the incurable through technology and teamwork

How does technology develop from a proof of concept, to a research project and ultimately to a commercial offering? Collaboration with innovative industry leaders is key. Carla Kriwet will participate on a panel session to discuss the recent launch of Philips IntelliSpace Epidemiology, the only decision-support solution to combine clinical informatics and genomic sequencing to help identify hospital acquired infections, which kill more people each year than breast cancer and prostate cancer combined. Moderated by Alan Murray, President and CEO of FORTUNE, Carla will be joined by Dr. Caroline Buckee, Associate Professor of Epidemiology at Harvard University, Dr. Julie Gerberding, Executive Vice President and Chief Patient Officer at Merck, and Peter Sands, Executive Director, The Global Fund for AIDS, Tuberculosis and Malaria.

Event: FORTUNE Brainstorm Health

Where: San Diego, CA

Date: April 2, 2019, 5:40pm PST

Website: https://www.fortuneconferences.com/fortune-brainstorm-health-2019/

Social Hashtag: #BrainstormHealth

Join the livestream of the panel session starting at 5:40pm PST at: www.fortune.com/BSHLive.

Speaker: Dr. Carla Kriwet

Chief Business Leader, Connected Care, Philips

Dr. Carla Kriwet is Executive Vice President and Chief Business Leader of Connected Care at Philips, and a member of the Royal Philips Executive Committee. Carla has more than 20 years of experience in business strategy and operational execution in the industrial and medical device industries.